EUVIMEDSkopri EUVIMED
Crossref

Naringenin relieves paclitaxel‐induced pain by suppressing calcitonin gene‐related peptide signalling and enhances the anti‐tumour action of paclitaxel

Chen Pan, Yuhao Xu, Zongsheng Jiang, Chengjiang Fan, Zhexi Chi, Yu Zhang, Mengmeng Miao, Yuxuan Ren, Ziyi Wu, Linbin Xu, Changqing Mei, Qingge Chen and 2 more

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.16397 ↗

At a glance

Journal article in British Journal of Pharmacology, 2024. Written by Chen Pan and 13 co-authors. Institution: Zhejiang Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo, China. Major MEDLINE topics: Paclitaxel, Flavanones, Calcitonin Gene-Related Peptide, Signal Transduction. Cited 8 times so far (Crossref); 74 references. Funded by: Natural Science Foundation of Zhejiang Province, Natural Science Foundation of Ningbo Municipality (Major Program), National Natural Science Foundation of China.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background and Purpose Chemotherapy‐induced peripheral neuropathy (CIPN) commonly causes neuropathic pain, but its pathogenesis remains unclear, and effective therapies are lacking. Naringenin, a natural dihydroflavonoid compound, has anti‐inflammatory, anti‐nociceptive and anti‐tumour activities. However, the effects of naringenin on chemotherapy‐induced pain and chemotherapy effectiveness remain unexplored. Experimental Approach Female and male mouse models of chemotherapy‐induced pain were established using paclitaxel. Effects of naringenin were assessed on pain induced by paclitaxel or calcitonin gene‐related peptide (CGRP) and on CGRP expression in dorsal root ganglia (DRG) and spinal cord tissue. Additionally, we examined peripheral macrophage infiltration, glial activation, c‐fos expression, DRG neuron excitability, microglial M1/M2 polarization, and phosphorylation of spinal NF‐ κ B. Furthermore, we investigated the synergic effect and related mechanisms of naringenin and paclitaxel on cell survival of cancer cells in vitro. Key Results Systemic administration of naringenin attenuated paclitaxel‐induced pain in both sexes. Naringenin reduced paclitaxel‐enhanced CGRP expression in DRGs and the spinal cord, and alleviated CGRP‐induced pain in naïve mice of both sexes. Naringenin mitigated macrophage infiltration and reversed paclitaxel‐elevated c‐fos expression and DRG neuron excitability. Naringenin decreased spinal glial activation and NF‐ κ B phosphorylation in both sexes but influenced microglial M1/M2 polarization only in females. Co‐administration of naringenin with paclitaxel enhanced paclitaxel's anti‐tumour effect, impeded by an apoptosis inhibitor. Conclusion and Implications Naringenin's anti‐nociceptive mechanism involves CGRP signalling and neuroimmunoregulation. Furthermore, naringenin facilitates paclitaxel's anti‐tumour action, possibly involving apoptosis. This study demonstrates naringenin's potential as a supplementary treatment in cancer therapy by mitigating side effects and potentiating efficacy of chemotherapy.

Subjects

MeSH terms (MEDLINE)

PaclitaxelFlavanonesCalcitonin Gene-Related PeptideSignal TransductionAntineoplastic Agents, PhytogenicAnimalsMaleFemaleMiceGanglia, SpinalAnalgesicsMice, Inbred C57BLHumansCell Line, TumorSpinal CordPain

Author keywords

CGRPCIPNapoptosiscancernaringeninpaclitaxelpain

Substances

PaclitaxelnaringeninFlavanonesCalcitonin Gene-Related PeptideAntineoplastic Agents, PhytogenicAnalgesics

Authors and institutions

  • Zhejiang Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo, China.
  • Department of Anesthesiology, Ningbo No. 2 Hospital, Ningbo, China.
  • Department of Anesthesiology, The People's Hospital of Bozhou, Bozhou, China.

ORCID profiles: Xiaowei Chen

Funding

  • Natural Science Foundation of Zhejiang Province
  • Natural Science Foundation of Ningbo Municipality (Major Program)
  • National Natural Science Foundation of China

Cite

APA

Pan, C., Xu, Y., Jiang, Z., Fan, C., Chi, Z., Zhang, Y., Miao, M., Ren, Y., Wu, Z., Xu, L., Mei, C., Chen, Q., Xi, Y., & Chen, X. (2024). Naringenin relieves paclitaxel‐induced pain by suppressing calcitonin gene‐related peptide signalling and enhances the anti‐tumour action of paclitaxel. British Journal of Pharmacology. https://doi.org/10.1111/bph.16397

Vancouver

Pan C, Xu Y, Jiang Z, Fan C, Chi Z, Zhang Y, et al. Naringenin relieves paclitaxel‐induced pain by suppressing calcitonin gene‐related peptide signalling and enhances the anti‐tumour action of paclitaxel. British Journal of Pharmacology. 2024. doi:10.1111/bph.16397

BibTeX
@article{Pan2024,
  author = {Pan, Chen and Xu, Yuhao and Jiang, Zongsheng and Fan, Chengjiang and Chi, Zhexi and Zhang, Yu and Miao, Mengmeng and Ren, Yuxuan and Wu, Ziyi and Xu, Linbin and Mei, Changqing and Chen, Qingge and Xi, Yang and Chen, Xiaowei},
  title = {Naringenin relieves paclitaxel‐induced pain by suppressing calcitonin gene‐related peptide signalling and enhances the anti‐tumour action of paclitaxel},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.16397}
}
Start for free →